Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV [clinicaltrials:NCT00056797]
Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV [clinicaltrials:NCT00056797]
Bio2RDF identifier
NCT00056797
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00056797
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
This study will evaluat ...... people with HIV infection.
brief title [clinicaltrials_vocabulary:brief-title]
Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
While the advent of hig ...... ocyte dynamics are monitored.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2003-03-24T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
HIV Therapeutic vaccine
Structured Treatment Interruption
Treatment Experienced
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2010-06-18T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00056797
official title [clinicaltrials_vocabulary:official-title]
A Randomized Controlled Study ...... ntiretroviral Therapy (HAART).
org study id [clinicaltrials_vocabulary:org-study-id]
1R01AI51181-01A1
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2007-07-01T00:00:00Z
identifier
clinicaltrials:NCT00056797
title
Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV
@en
type
label
Therapeutic HIV Vaccine and In ...... V [clinicaltrials:NCT00056797]
@en